GelMEDIX
PrivateLast Round
Seed
Feb 17, 2026
Total Funding Raised
$34.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GelMEDIX operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in February 2026.
GelMEDIX is a biotechnology company developing regenerative therapies that restore vision by regenerating damaged retinal cells using a proprietary injectable hydrogel scaffold platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GelMEDIX Comparables
Compare GelMEDIX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Paldara Pharmaceuticals | 81% | |
| Tempo Therapeutics, Inc. | 79% | |
| OncoLize | 79% |
For institutional investors. Book with your work email.
GelMEDIX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 17, 2026 | ||||
| VC Round | Jan 8, 2026 | ||||
| Seed | Oct 20, 2025 | ||||
| Seed Round | Oct 1, 2025 | ||||
| Debt | Mar 26, 2024 | ||||
Series A | Aug 9, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GelMEDIX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TiE Boston | Seed |
| Beacon Angels | Seed |
| Safar Partners | Series A, Seed |
| TiE Boston Angels | Seed |
| Boston Harbor Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
$13M round led by Safar Partners.
- Oct 1, 2025
$747K raised in Seed Round.
For institutional investors. Book with your work email.
GelMEDIX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GelMEDIX's valuation, stock price, and market status.
Is GelMEDIX a public or private company?
GelMEDIX is a private company.
What is the current stock price of GelMEDIX?
GelMEDIX is a private company, so its shares have no public market price. Caplight tracks GelMEDIX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GelMEDIX worth (valuation)?
Valuation information for GelMEDIX is not publicly available.
Can I buy GelMEDIX stock?
GelMEDIX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GelMEDIX's last funding round?
GelMEDIX's most recent funding round was Seed on February 17, 2026.
Who are the main investors in GelMEDIX?
Key investors in GelMEDIX include Safar Partners.
Will GelMEDIX IPO soon?
No public IPO plans have been announced for GelMEDIX.
How can I track GelMEDIX secondary market activity?
Caplight tracks bids, offers, and trades in GelMEDIX's shares on secondary markets.